DDC
Daniel Devine & Co Portfolio holdings
AUM
$125M
This Quarter Return
+6.12%
1 Year Return
+14.12%
3 Year Return
+34.19%
5 Year Return
–
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(+5.7%)
Cap. Flow
+$2.57M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
69.63%
Holding
50
New
1
Increased
2
Reduced
20
Closed
2
Top Buys
| 1 |
iShares Biotechnology ETF
IBB
|
$3.03M |
| 2 |
Target
TGT
|
$715K |
Top Sells
| 1 |
GE Aerospace
GE
|
$1.85M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
$161K |
| 3 |
Johnson & Johnson
JNJ
|
$119K |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$117K |
| 5 |
CNBKA
Century Bancorp Inc/Mass
CNBKA
|
$115K |
Sector Composition
| 1 | Healthcare | 12.46% |
| 2 | Financials | 6.95% |
| 3 | Technology | 6.71% |
| 4 | Energy | 3.05% |
| 5 | Consumer Staples | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $32.4M | 23.46% |
121,537
-440
| -0.4% | -$117K |
|
2
Invesco QQQ Trust
QQQ
$364B
| $18M | 13.03% |
115,630
| – | – |
|
3
SPDR S&P MidCap 400 ETF Trust
MDY
$23.7B
| $16.1M | 11.65% |
46,615
| – | – |
|
4
Apple
AAPL
$3.45T
| $8.19M | 5.92% |
48,398
-165
| -0.3% | -$27.9K |
|
|
5
Johnson & Johnson
JNJ
$427B
| $4.97M | 3.59% |
35,557
-850
| -2% | -$119K |
|
|
6
iShares Biotechnology ETF
IBB
$5.6B
| $4.55M | 3.29% |
42,585
+28,390
| +200% | +$3.03M |
|
7
iShares MSCI Emerging Markets ETF
EEM
$19B
| $3.23M | 2.34% |
68,600
| – | – |
|
8
Berkshire Hathaway Class B
BRK.B
$1.09T
| $3.11M | 2.25% |
15,700
| – | – |
|
9
AbbVie
ABBV
$372B
| $2.96M | 2.14% |
30,580
| – | – |
|
10
Chevron
CVX
$324B
| $2.7M | 1.95% |
21,574
-294
| -1% | -$36.8K |
|
11
Visa
V
$683B
| $2.31M | 1.67% |
20,280
-200
| -1% | -$22.8K |
|
12
Pfizer
PFE
$141B
| $2.16M | 1.56% |
59,662
-650
| -1% | -$23.5K |
|
13
FedEx
FDX
$54.5B
| $2.12M | 1.54% |
8,510
-150
| -2% | -$37.4K |
|
14
UnitedHealth
UNH
$281B
| $1.98M | 1.43% |
8,965
-150
| -2% | -$33.1K |
|
15
Costco
COST
$418B
| $1.87M | 1.36% |
10,065
| – | – |
|
16
Novartis
NVS
$245B
| $1.82M | 1.32% |
21,650
| – | – |
|
17
Zoetis
ZTS
$69.3B
| $1.74M | 1.26% |
24,190
| – | – |
|
18
Blackrock
BLK
$175B
| $1.73M | 1.25% |
3,360
-100
| -3% | -$51.4K |
|
19
Starbucks
SBUX
$100B
| $1.7M | 1.23% |
29,615
| – | – |
|
20
Walt Disney
DIS
$213B
| $1.63M | 1.18% |
15,152
-150
| -1% | -$16.1K |
|
21
Alphabet (Google) Class C
GOOG
$2.58T
| $1.55M | 1.12% |
1,469
| – | – |
|
|
RDS.B
22
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.52M | 1.1% |
22,225
| – | – |
|
23
AstraZeneca
AZN
$248B
| $1.3M | 0.94% |
37,400
| – | – |
|
|
24
Target
TGT
$43.6B
| $1.3M | 0.94% |
19,860
+10,960
| +123% | +$715K |
|
25
Hanesbrands
HBI
$2.23B
| $1.27M | 0.92% |
60,695
| – | – |
|